Loading...
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Hemoglobin A1c values may underestimate past glucose concentrations in black patients with sickle cell trait, suggests a retrospective study in JAMA.
Researchers studied over 4600 black adults from two community-based cohorts. Together, participants contributed 9000 concurrent fasting glucose and HbA1c measurements plus 2000 concurrent 2-hour glucose and HbA1c measurements for analysis. Roughly 8% of participants had sickle cell trait.
Overall, the mean HbA1c value was lower in those with than without sickle cell trait (5.7% vs. 6.0%). After multivariable adjustment — and when glucose measurements were the same in those with and without sickle cell trait — HbA1c was significantly lower with sickle cell trait. Further, the prevalence of diabetes — when defined by HbA1c value — was significantly lower with sickle cell trait (3.8% vs. 7.3%).
The researchers note that in patients with sickle cell trait, red blood cells may have a shorter lifespan, allowing less time for glycation and therefore reduced HbA1c concentration. Editorialists recommend that clinicians consider oral glucose tolerance testing when HbA1c approaches 6.5% in black patients with sickle cell trait.
Comment
LINK(S):
JAMA article (Free abstract)
JAMA editorial (Subscription required)
Background: NEJM Journal Watch Oncology and Hematology coverage of study examining sickle cell trait as a cardiovascular risk factor (Your NEJM Journal Watch subscription required)